HealthEquity reported a slight revenue increase to $180.0 million, but experienced a net loss of $5.0 million, contrasting with a net income of $1.8 million in the same quarter last year. Non-GAAP net income was $28.9 million. The company saw a 14% increase in HSAs to 6.2 million and a 32% increase in total HSA assets to $16.4 billion. Key acquisitions of Fifth Third Bank HSA portfolio and Further were completed during and after the quarter.
Revenue increased slightly to $180.0 million, up less than 1% year-over-year.
Net loss was $5.0 million, a significant change from the $1.8 million net income in Q3 FY21.
Total HSAs grew by 14% to 6.2 million, with total HSA assets increasing by 32% to $16.4 billion.
Completed acquisition of Fifth Third Bank HSA portfolio and Further, adding a substantial number of new HSAs.
For the fiscal year ending January 31, 2022, HealthEquity anticipates revenues between $750 million and $755 million, a net loss between $36 million and $33 million, and non-GAAP net income between $108 million and $112 million. Adjusted EBITDA is expected to be between $230 million and $235 million. This outlook includes the impact of recent acquisitions and financing activities.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance